NK-Cell Count and Its Function in Producing Interferon Gamma Associated with the Cervical Cancer Natural History
Received Date: Jan 19, 2018 / Accepted Date: Feb 10, 2018 / Published Date: Feb 17, 2018
Objective: Natural killer cell (NK-cell) has an important role in tumor immunosurveilance. We investigate the NKcell count and its function in producing IFN-γ on normal cervix, subclinical high risk-HPV (hr-HPV) infection, precancerous lesion of cervix, and cervical cancer in order to understand the natural history of uterine cervical cancer.
Methods: This is a descriptive comparative numerical study with more than two unpaired group with total subjects of 40 females who met the inclusion and exclusion criteria. Samples were gathered from cervical tissue using cytobrush and were processed in the laboratory to calculate NK-cell count and NK-cell expression of IFN-γ by phyta hemagglutinin (PHA) stimulation using flow cytometry. Data was analyzed using Kruskal Wallis and post hoc analysis was done to determine the difference between groups.
Results: The mean NK-cell count on normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer were 2.6%, 11.6%, 12%, and 7.4%. The mean NK-cell producing IFN-γ on normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer were 8.1%, 3.3%, 1.1%, and 1.8%. There is significant difference of NK-cell count between 4 groups (p=0.001) but there is no significant difference of NK-cell producing IFN-γ (p=0.577).
Conclusion: NK-cell count on normal cervix was significantly lower than other group but it has highest expression of IFN-γ after stimulation. On the other hand, precancerous lesion and cervical cancer has lower expression of IFN-γ after stimulation. Eventhough statistically there is no NK-cell activity difference, this study shows that NK-cell activity in disease groups were impaired. Further study is needed to understand NK-cell activity and its role in cervical cancer natural history. Nowdays, NK-cells as immunotherapy are potential tools for cancer therapy. In the future, we hope that NK-cell activity can be a parameter of cervical cancer progression and strategy to treat cervical cancer.
Keywords: NK-cell; IFN-γ; Cervical Cancer; HPV; Precancerous lesion
Cervical cancer is one of the main health issues and the second most common female malignant neoplasm in Indonesia. There were 20.928 new cases of cervical cancer and 9498 cancer-related deaths in 2012 in Indonesia. In years to come, it is predicted that there will be an increase in new cases and mortality since there hasn’t been any effective prevention and treatment program [1,2].
Cervical cancer is one of the cancers that can be prevented because the etiology is known. Human Papilloma Virus (HPV) has been acknowledged as the etiology of cervical cancer. Although HPV is well established to be the cause of cervical cancer, only a small percentage of HPV infections will develop clinically or histologically recognizable lesion . Most of the infections will have resolutions and about 70-90 percent of HPV infection would not be detected in 1-2 years. High-risk HPV (hr-HPV) infection that has oncogenic characteristic is the most important factor contributing to the progression of HPV infection into cervical cancer . However, there were other contributing factors, such as host immune response [5,6]. Innate immune response represent the first line the first line of defense against HPV infection and transforming cells. If the host has good immune response, the infection will be cleared or become subclinical .
Natural killer cell (NK-cell) has an important role in tumor immunosurveilance.8 NK-cell has the capacity to recognize and eliminate infected cells and transformed cell without prior sensitization by: (1) its cytotoxic activity through secretion of perforin/granzym and (2) cytokine production [8-11]. Some studies found that there was a decreasing number of NK-cell and its activity in cervical cancer. Interferon gamma (IFN-γ) is one of the cytokines produced by activated NK-cell. It is believed that that (IFN-γ) can control viral infection by increasing NK-cell cytotoxic activity. In some studies, higher (IFN-γ) correlates with higher clearance in high-risk HPV infection, while low (IFN-γ) is found in women with cervical cancer [12,13].
There are still few studies that explore NK-cells and its activity in relation with the natural progression of cervical cancer. The role of NK-cell and its (IFN-γ) secreting activity related to HPV infection and progressivity hasn't been fully understood. From the clinical perspective, NK-cell count and its activity can be used as the risk indicator of cervical cancer, especially in high-risk population. Nowdays, NK-cells used as immunotherapy are potential tools for cancer therapy. If proven significant, the result of this study can be used as a new strategy in secondary and tertiary prevention against cervical cancer.
Natural killer cell (NK-cell) has an important role in tumor immunosurveilance. We hypothesized that there will be a variance in NK-cell counts and its activity in different population. We investigate the NK-cell count and its function in producing IFN-γ on normal cervix, subclinical high risk-HPV (hr-HPV) infection, precancerous lesion, and cervical cancer in order to understand the natural history of uterine cervical cancer.
This study is a cross-sectional study with total sample of 40 female subjects. The subjects were divided into four groups of: normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer. Each group consists of 10 female subjects.
Inclusion criteria in this study were: sexually active women aged 20-60 years old; normal cytology and negative HPV DNA (group 1); normal cytology with positive hr-HPV DNA (group 2); abnormal cytology in precancerous lesion with positive or negative HPV DNA (group 3); abnormal histopathology result in cervical cancer (group 4); and signed consent to be included in the study. Exclusion criteria were menstruation, malnutrition, pregnancy, presence of autoimmune disease or HIV, long-term steroid medication, and genito-urinary tract infection.
Cervico-vaginal samples were taken by cytobrush from the subjects who met all the inclusion and exclusion criteria. Samples were transferred into tubes containing buffer and were processed in the laboratory to calculate the NK-cell count and NK-cell expression of IFN-γ after phytahemagglutinin (PHA) stimulation. Flow cytometry analysis was done to determine the number of NK-cell (CD16+ CD56+ dan CD3-) and NK-cell expressing IFN-γ. The number of NK-cell was compared with the number of CD45+ (in percentage.)
Data was analyzed using SPSS version 23. This is a descriptive comparative numerical study with more than two unpaired group. Data was analyzed Kruskal Wallis. Post hoc analysis was done if there were any significant different between groups. This study was approved by Ethics Committee for Health Researches Faculty of Medicine Universitas Indonesia.
There were total 40 subjects: 10 subjects with normal cervix; 10 subjects with subclinical hr-HPV infection; 10 subjects with precancerous lesion and 10 subjects with cervical cancer. The mean age of subjects was 45.6 years old. Mean age of subjects in groups of normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer were 47 years old, 44.5 years old, 41 years old and 48 years old. In hr-HPV group, 5 patients (50%) had mono-infection and 5 patients (50%) had multiple hr-HPV infection. The most common hr-HPV type was type 52 (5 patients), type 16 (3 patients) and type 66/68 (3 patients). Types of hr-HPV in subclinical infection were shown in Table 1.
|HPV Types||Subclinical hr-HPV infection (n=10)*|
*5 subjects have multiple HPV infection
Table 1: Types of hr-HPV detected in subclinical infection.
In this study, mean NK-cell count in four groups of normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer were: 2.6%, 11.6%, 12%, and 7.4% respectively. The lowest proportion was in normal cervix group (2.6%), while the highest proportion was in precancerous lesion group (12%). Analysis was performed using Kruskal Wallis. The analysis produced significant difference in NK-cell count (p=0.001) between 4 subject groups (Table 2).
|Variable||n||Mean (SD)||Median (Min-Max)||P Value#|
|Number of NK-cell (%)||0.001|
|Normal cervix||10||2.60 (0.96)||2.5 (1-4)|
|Subclinical HPV infection||10||11.6 (10.88)||7.5 (2-38)|
|Precancerous lesion||10||12.00 (8.93)||10.5 (3-31)|
|Cervical cancer||10||7.40 (2.91)||7.5 (1-11)|
#Analysis using Kruskal Wallis
Table 2: NK-cell count.
Post-hoc analysis was performed using Mann Whitney and there were significant difference between these groups:
(1) normal cervix and subclinical infection.
(2) normal cervix and subclinical infection.
(3) normal cervix can cervical cancer. This study found no significant NK-cell count difference between the cervical cancer and subclinical hr-HPV group; and the precancerous lesion and cervical cancer group (Table 3). Flow cytometry analysis of NK-cell count is depicted in Figure 1.
|Comparison of NK-cell count||P Value|
|Normal cervix vs subclinical hr-HPV infection||0.001|
|Normal cervix vs precancerous lesion||0.001|
|Normal cervix vs cervical cancer||0.002|
|Subclinical hr-HPV infection vs precancerous lesion||0.571|
|Subclinical hr-HPV infection vs cervical cancer||0.571|
|Cervical cancer vs precancerous lesion||0.548|
Table 3: Post-hoc Mann Whitney analysis of NK-cell count.
NK-cell activity in producing IFN-γ
After measuring the number of NK-cells, this study was followed by assessing the activity of NK-cell in producing IFN-γ. Flow cytometry was used to evaluate the intracellular activity of NK-cell (Figure 2). The mean number of NK-cell producing IFN-γ in normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer were 8.1%, 3.3%, 1.1% and 1.8% respectively. Kruskal Wallis analysis between those 4 groups yields no significant result. The result is depicted in Table 4.
|Variable||n||Mean (SD)||Median (Min-Max)||P Value#|
|NK-cell producing IFN-γ (%)||0.577|
|Normal cervix||10||8.145 (16.63)||0.745 (0.1-49.6)|
|Subclinical HPV infection||10||3.393 (6.40)||1.35 (0.13-21.15)|
|Precancerous lesion||10||1.1750 (1.61)||0.63 (0.02-5.56)|
|Cervical cancer||10||1.871 (3.20)||0.375 (0.06-8.39)|
#Analysis using Kruskal Wallis
Table 4: Number of NK-cell producing IFN-γ.
Natural killer cells are important components of the innate immune system, owing to their cytokine production and cytotoxic activity against target cells. In clinical settings, in vitro NK-cell activity has been an important predictor of possible correlations between NK-cell activity and disease outcome or progression. NK-cell count will increase if there is an exposure from external pathogen. Viral infected cells, tumor cells or inflammation will trigger signaling cascade that can affect the immune response.
In this study, mean NK-cell count in four groups of normal cervix, high risk HPV (hr-HPV) subclinical infection, precancerous lesion, and cervical cancer were: 2.6%, 11.6%, 12%, and 7.4% respectively. The lowest NK-cell count was in normal cervix group. This result is in accordance with another study by Trinova, et al. (NK-cell count 2.7% in normal cervix group) . The result showed that without any external stimuli or the presence of inflammation, NK-cell count will be relatively low in cervix. Conversely, in groups with subclinical hr-HPV infection, precancerous lesion, and cervical cancer, there was an increase of NK-cell count. It was inferred that infection process or chronic infection could increase the number of NK-cells. In some cancer patients, the increase of NK-cell counts was associated with better prognosis; however it also relied on the remaining functional NK-cell during tumourogenesis .
IFN-γ is one of the important cytokines produced by NK-cells that can act as an antivirus and tumor regulation [16,17]. HPV virus has a few avoidance mechanisms from the innate immune response. One of them is by interfering the production of IFN-γ through oncogenic protein in hr-HPV (protein E6 and E7). IFN-γ can increase the activity of NK-cells and macrophage activity; and work together with dendritic cells to induce the differentiation of T-helper [18-20]. In this study, the mean number of NK-cell producing IFN-γ in normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer were 8.1%, 3.3%, 1.1% and 1.8% respectively. Nevertheless, there wasn't any statistical significance between the subject groups (p=0.557). In one study, it was found that in higher IFN-γ, hr-HPV infection tend to have higher clearance rate; while other study also showed that women with cervical cancer tend to have lower IFN-γ level . However, there are also studies that indicate that IFN-γ level is not significantly different between healthy group and cervical cancer group [21,22]. Correlation IFN-γ and cervical cancer progression still unclear. Eventhough statistically there is no activity different between groups, but from the result we can see the mean of nk-cell expressing IFN-γ on normal cervix group has the highest number. It shows the NK-cell activity on disease groups were impaired. We still cannot conclude the different NK-cell activity between groups, because the power of this study is small.
Although one of the functions of NK-cell is releasing cytokines, such as IFN-γ, it doesn't represent all of NK-cell function. One of the main functions of NK-cell is its cytotoxic activity that can recognize pathogen without prior sensitization. While those two functions correlates with each other, they have different activating mechanism (Park, et al.). Although there was no statistical significance in NK-cell producing IFN-γ between the groups, the cytotoxic activity of NK-cell also couldn’t be determined which was not explored in this study. Hence, the whole function of NK-cell couldn't be observed entirely.
This is one of few studies that show the correlation between NK-cell count and cervical cancer natural history using samples from cervical tissue. Through cervical tissue samples, we can associate the number and activity of NK-cell with the natural history of HPV infection locally. Nevertheless, this study cannot portray the whole picture of cervical cancer natural history. The weakness of this study is the number of sample, which is still lacking.
The highest mean NK-cell count in four groups of normal cervix, high risk HPV (hr-HPV) subclinical infection, precancerous lesion, and cervical cancer are: 2.6%, 11.6%, 12%, and 7.4% respectively. There is statistical significance between subject groups (p=0.001). The lowest number found on normal cervix (2.6%), it shows no exposure from pathogen that increase NK-cell number. The mean number of NK-cell producing IFN-γ in normal cervix, subclinical hr-HPV infection, precancerous lesion, and cervical cancer are 8.1%, 3.3%, 1.1% and 1.8% respectively. There is no statistical significance in NK-cell producing IFN-γ between the subject groups, but normal cervix group have the highest NK-cell expressing IFN-γ. It shows that on diseases group the activity were impaired even though we cannot conclude because the power of the study is still lacking. There is a need for further studies with more samples and a follow through study to generate more conclusive result. On the future, we hope that NK-cell activity can be a parameter of cervical cancer progression and strategy to treat cervical cancer.
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. (2012) Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France. GLOBOCAN 1-2.
- HPV and related disease in Indonesia. ©ICO Information Centre on HPV and Cancer (HPV Information Centre), 2016.
- Narisawa-Saito M, Kiyono T (2007) Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. J Cancer Sci 98: 1505-1511.
- Koshiol J, Lindsay L, Pimenta JM, Pooled C, Jenkins D (2008) Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis. Am J Epidemiol 168: 123-137.
- Au WW, Abdou-Salama S, Sierra-Torres CH, Al-Hendy A (2007) Environmental risk factors for prevention and molecular intervention of cervical cancer. Int J Hyg Environ Health 210: 671-678.
- Frazer IH (2009) Interaction of human papillomaviruses with the host immune system: A pellet evolved relationship. Virol 384: 410-414.
- Tindle RW (2002) Immune evasion in human papillomavirus-associated cervical cancer. Nat Revs Cancer 2: 59-65.
- Molina AA, Valencia JFH, Lamoyi E (2013) Role of innate immunity against Human Papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. J Viruses 5: 2624-2642.
- Langers I, Renoux VM, Thiry M (2012) Natural killer cells : Role in local tumor growth and metastasis. Biologics: Targets and Therapy 6: 73-82.
- Park-Wittel MA, Yang L (2013) Interferon-? mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc Natl Acad Sci USA 110: 50-59.
- Valiathan R, Lewis JE, Melillo AB (2012) Evaluation of a Flow Cytometry-Based Assay for Natural Killer Cell Activity in Clinical Settings. Scandinavian Journal of Immunology 75: 455-462.
- Song SH, Lee JK, Lee NW (2007) Interferon-F (IFN-F):a possible prognostic marker for clearance of highrisk human papillomavirus (HPV). Gynecol Oncol 108: 543-548.
- Lebrecht A, Hefler L, Tempfer C (2001) Serum cytokine concentrations in patients with cervical cancer: interleukin-4, interferon-gamma, and monocyte chemoattractant protein-1. Gynecol Oncol 83: 170-171.
- Trifonova RT, Lieberman J, van Baarle D (2014) Distribution of immune cells in the human cervix and implications for HIV transmission. Am J Reprod Immunol 71: 252-264.
- Stojanovic A, Correia MP, Cerwenka A (2013) Shaping of NK-cell Responses by the Tumor Microenvironment. Cancer Microenvironment 6: 135-146
- Fauriat C, Long EO, Ljunggren HG (2010) Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 155: 2167-2176.
- Paolini R, Bernardini G, Molfetta R, Santoni A (2015) NK cells and interferons. Cytokine Growth Factor Rev 26: 113-120.
- Mishra R, Welsh R, Szomolanyi-Tsuda E (2014) NK cells and virus-related cancers. Crit Rev Oncog 19: 107-119.
- Song D, Li H, Dai J (2015) Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer (Review). Oncol Let 10: 600-606
- Kanodia S, Fahey LM, Kast WM (2007) Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response. Current Cancer Drug Targets 7: 79-89.
- Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, et al. (2001) Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7: 285-289.
- Hong JW, Kim MK, Kim TJ (2010) Association Between Serum Cytokine Profiles and Clearance or Persistence of High-Risk Human Papillomavirus Infection. A Prospective Study. Int J Gynecol Cancer 20: 1011-1016.
Citation: Utami TW, Parsaoran MM (2018) NK-Cell Count and Its Function in Producing Interferon Gamma Associated with the Cervical Cancer Natural History. Gynecol Obstet 8: 462. Doi: 10.4172/2161-0932.1000462
Copyright: ©2018 Utami TW, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
7th International Conference on Clinical and Medical Case Reports June 01-02, 2018 Osaka, Japan Theme: Focusing the breakthroughs of case reports in Clinical & Medical Research
June 01-02, 2018 Osaka, Japan
7th International Conference and Exhibition on Surgery June 21-23, 2018 Dublin, Ireland Theme: Advancements and Endeavours in the Field of Surgery
June 21-23, 2018 Dublin, Ireland Dublin, Ireland
Annual Congress on Research and Innovations in Medicine July 02-03, 2018 Bangkok, Thailand Theme: Current Research and Innovations in Medicine to Improve Human Health
July 02-03, 2018 Bangkok, Thailand
International Conference on Medical and Health Science August 24-25, 2018 Tokyo, JAPAN Theme: Scrutinize the Modish of Medical and Health Science
August 24-25, 2018 Tokyo, Japan
World Summit on Trauma and Reconstructive Surgery Sep 10-11, 2018 Singapore Theme: Expanding new horizons in Trauma and Surgery
Sep 10-11, 2018 Singapore City, Singapore
6th American Gynecological Surgery Conference September 28-29, 2018 San Antonio | Texas | USA
September 28-29, 2018 San Antonio, USA
World Congress on Fetal and Maternal Medicine October 15-17, 2018 Osaka, Japan Theme: A New Beginning on Fetal, Maternal & Neonatal Medicine
October 15-17, 2018 Osaka, Japan
International Conference on Reproduction and Fertility October 18-19, 2018 Abu Dhabi, UAE
October 18-19, 2018 Abu Dhabi, UAE
- Total views: 339
- [From(publication date): 0-2018 - May 27, 2018]
- Breakdown by view type
- HTML page views: 312
- PDF downloads: 27